FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

395893005: Tacalcitol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469833015 Tacalcitol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489529010 Tacalcitol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1863251000195118 tacalcitolo it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
191971000077112 tacalcitol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tacalcitol (substance) Is a agent antimitotique false Inferred relationship Some
Tacalcitol (substance) Is a agent cutané false Inferred relationship Some
Tacalcitol (substance) Is a Mitotic inhibitor true Inferred relationship Some
Tacalcitol (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Mitotic inhibitor (disposition) true Inferred relationship Some
Tacalcitol (substance) Is a Steroid true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing tacalcitol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tacalcitol (substance) Inferred relationship Some 1
Product containing precisely tacalcitol (as tacalcitol monohydrate) 4 microgram/1 gram conventional release cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tacalcitol (substance) Inferred relationship Some
Tacalcitol monohydrate (substance) Is a False Tacalcitol (substance) Inferred relationship Some
Product containing precisely tacalcitol (as tacalcitol monohydrate) 4 microgram/1 gram conventional release cutaneous ointment This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Tacalcitol (substance) Inferred relationship Some 1
Tacalcitol monohydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Tacalcitol (substance) Inferred relationship Some
Tacalcitol-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tacalcitol (substance) Inferred relationship Some 1
Product containing only tacalcitol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tacalcitol (substance) Inferred relationship Some 1
Product containing only tacalcitol in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tacalcitol (substance) Inferred relationship Some 1
Product containing precisely tacalcitol 4 microgram/1 gram conventional release cutaneous ointment (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tacalcitol (substance) Inferred relationship Some 1
Product containing precisely tacalcitol 4 microgram/1 gram conventional release cutaneous ointment (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tacalcitol (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start